249 related articles for article (PubMed ID: 24597542)
21. Tigecycline: a review of a new glycylcycline antibiotic.
Scheinfeld N
J Dermatolog Treat; 2005; 16(4):207-12. PubMed ID: 16249141
[TBL] [Abstract][Full Text] [Related]
22. A review of tigecycline.
French GL
J Chemother; 2008 Oct; 20 Suppl 1():3-11. PubMed ID: 19036669
[TBL] [Abstract][Full Text] [Related]
23. Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp.: experience with tigecycline.
Curcio D; Fernández F; Vergara J; Vazquez W; Luna CM
J Chemother; 2009 Feb; 21(1):58-62. PubMed ID: 19297274
[TBL] [Abstract][Full Text] [Related]
24. Tigecycline: an antibiotic for the twenty-first century.
Dryden M
J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii3-4. PubMed ID: 23772044
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies.
Eckmann C; Montravers P; Bassetti M; Bodmann KF; Heizmann WR; Sánchez García M; Guirao X; Capparella MR; Simoneau D; Dupont H
J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii25-35. PubMed ID: 23772043
[TBL] [Abstract][Full Text] [Related]
26. Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies.
Guirao X; Sánchez García M; Bassetti M; Bodmann KF; Dupont H; Montravers P; Heizmann WR; Capparella MR; Simoneau D; Eckmann C
J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii37-44. PubMed ID: 23772045
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies.
Montravers P; Bassetti M; Dupont H; Eckmann C; Heizmann WR; Guirao X; García MS; Capparella MR; Simoneau D; Bodmann KF
J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii15-24. PubMed ID: 23772042
[TBL] [Abstract][Full Text] [Related]
28. All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials.
McGovern PC; Wible M; El-Tahtawy A; Biswas P; Meyer RD
Int J Antimicrob Agents; 2013 May; 41(5):463-7. PubMed ID: 23537581
[TBL] [Abstract][Full Text] [Related]
29. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens.
Poulakou G; Kontopidou FV; Paramythiotou E; Kompoti M; Katsiari M; Mainas E; Nicolaou C; Yphantis D; Antoniadou A; Trikka-Graphakos E; Roussou Z; Clouva P; Maguina N; Kanellakopoulou K; Armaganidis A; Giamarellou H
J Infect; 2009 Apr; 58(4):273-84. PubMed ID: 19344841
[TBL] [Abstract][Full Text] [Related]
30. Tigecycline treatment of critically ill patients: the LatinUser experience.
Curcio D; Vargas SW; Ugarte Ubiergo S; Varón F; Rojas Suarez J; Paz Chávez C; Curiale A;
Curr Clin Pharmacol; 2011 Feb; 6(1):18-25. PubMed ID: 21235466
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis.
Tasina E; Haidich AB; Kokkali S; Arvanitidou M
Lancet Infect Dis; 2011 Nov; 11(11):834-44. PubMed ID: 21784708
[TBL] [Abstract][Full Text] [Related]
32. Tigecycline: a new antibiotic.
Hylands J
Intensive Crit Care Nurs; 2008 Aug; 24(4):260-3. PubMed ID: 18554910
[TBL] [Abstract][Full Text] [Related]
33. Tigecycline : a critical safety review.
Kaewpoowat Q; Ostrosky-Zeichner L
Expert Opin Drug Saf; 2015 Feb; 14(2):335-42. PubMed ID: 25539800
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs.
Shen F; Han Q; Xie D; Fang M; Zeng H; Deng Y
Int J Infect Dis; 2015 Oct; 39():25-33. PubMed ID: 26283551
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of tigecycline in complicated skin and skin structure infections and complicated intra-abdominal infections.
Wilcox MH
J Chemother; 2005 Aug; 17 Suppl 1():23-9. PubMed ID: 16285355
[TBL] [Abstract][Full Text] [Related]
36. Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients.
Balandin Moreno B; Fernández Simón I; Pintado García V; Sánchez Romero I; Isidoro Fernández B; Romera Ortega MA; Alcántara Carmona S; Pérez Redondo M; Galdos Anuncibay P
Scand J Infect Dis; 2014 Mar; 46(3):175-80. PubMed ID: 24354959
[TBL] [Abstract][Full Text] [Related]
37. Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials.
Bassetti M; McGovern PC; Wenisch C; Meyer RD; Yan JL; Wible M; Rottinghaus ST; Quintana A
Int J Antimicrob Agents; 2015 Sep; 46(3):346-50. PubMed ID: 26155003
[TBL] [Abstract][Full Text] [Related]
38. Prospective, non-interventional, multi-centre trial of tigecycline in the treatment of severely ill patients with complicated infections: new insights into clinical results and treatment practice.
Eckmann C; Heizmann WR; Leitner E; von Eiff C; Bodmann KF
Chemotherapy; 2011; 57(4):275-84. PubMed ID: 21778715
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
40. Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution.
Chemaly RF; Hanmod SS; Jiang Y; Rathod DB; Mulanovich V; Adachi JA; Rolston KV; Raad II; Hachem RY
Medicine (Baltimore); 2009 Jul; 88(4):211-220. PubMed ID: 19593226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
